BioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio

MT Newswires Live

2025/04/07

BioLife Solutions (BLFS) said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.

The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.

BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.

BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2525487600"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2525487600\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2525487600?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-07 20:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2525487600","market":"fut","top_or_hot":-1,"title":"BioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio","media":"MT Newswires Live","content":"<html><body><p> BioLife Solutions (BLFS) said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.</p><p>The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.</p><p>BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.</p><p>BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBioLife Solutions Acquires PanTHERA CryoSolutions to Enhance Biopreservation Portfolio\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-04-07 20:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BioLife Solutions (BLFS) said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.</p><p>The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.</p><p>BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.</p><p>BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLFS","symbol_name":"BioLife Solutions Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2525487600","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2525487600","pubTimestamp":1744030605,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BioLife Solutions  said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLFS":"BioLife Solutions Inc.","BK4198":"医疗保健用品","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","BK4121":"生命科学工具和服务","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC"},"translate_title":"BioLife Solutions收购PanTHERA CryoSolutions以增强生物保存产品组合","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLFS":1},"content_text":"BioLife Solutions (BLFS) said Monday it acquired privately-held PanTHERA CryoSolutions, a cryopreservation solution developer utilizing proprietary ice recrystallization inhibitor technology, to strengthen its position in biopreservation by enhancing its product portfolio and adding scientific expertise to its management team.The company said it acquired 90% of PanTHERA shares it does not already own for $9.3 million in cash and 241,355 shares of its common stock.BioLife also said PanTHERA's shareholders may receive up to $7.2 million in BioLife stock over the next three years, contingent on achieving specific scientific and revenue milestones.BioLife said it initially invested in PanTHERA in 2020 through its Bioproduction Innovation Accelerator, co-sponsored with Casdin Capital.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,merge","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}